ANZCA-response-to-TGA-re-scheduling-changes-for-nitrous-oxide-20210204
101221-Protected-title-media-statement
Submission re Andexanet
College feedback to the Council of Therapeutic Advisory Groups on a draft position statement for andexanet alfa
DMH Supervisor of training nomination
Summary of concessions 2020
Prescribing medicinal cannabis for chronic non-cancer-pain
This fact sheet is from the Faculty of Pain Medicine, Australian
and New Zealand College of Anaesthetists. It is a summary
of our position on prescribing medicinal cannabis for people
with chronic pain.
Reg 36 - ANZCA advanced certificate in diving and hyperbaric medicine
Regulation 36 applies to all trainees undertaking the ANZCA Advanced Certificate in Diving and
Hyperbaric Medicine from 31 July 2017.
Patient experience survey (diving and hyperbaric medicine) - guideline
Patient experience survey (diving and hyperbaric medicine) - guideline
ANZCA-response-to-revised-MBA-CPD-registration
Use-of-off-label-or-drugs-beyond-licence-in-pain-medicine